Received Apr 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | DD72H | IM |
BEXSERO dose was given to patient on 11-apr 2025 they intended to administer is MenQuadfi; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 12-year-old male patient who received Men B NVS (Bexsero) (batch number DD72H, expiry date 30-NOV-2027) for prophylaxis. Co-suspect products included Meningococcal vaccine A/C/Y/W conj (tet tox) (Menquadfi) for prophylaxis. On 11-APR-2025, the patient received Bexsero (intramuscular) .5 ml. On an unknown date, the patient received Menquadfi. On 11-APR-2025, an unknown time after receiving Bexsero, the patient experienced wrong vaccine administered (Verbatim: BEXSERO dose was given to patient on 11-apr 2025 they intended to administer is MenQuadfi). The outcome of the wrong vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 15-APR-2025 The nurse reported that a Bexsero dose was given to a patient and stated that the medication they intended to administer was Menquadfi, which led to wrong vaccine administered.